Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Carro

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Expert Opinion on Therapeutic Targets|May 4, 2010
Gelsolin as therapeutic target in Alzheimer's diseaseEva Carro
Neural Regeneration Research|July 14, 2023
Implication of salivary lactoferrin and periodontal-mediated infections in Alzheimer's diseaseCristina Municio, Eva Carro
Neural Regeneration Research|December 26, 2022
Aquaporin 5 in Alzheimer's disease: a link between oral and brain pathology?Cristina Municio, Eva Carro
Frontiers in Pharmacology|May 8, 2012
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approachesAgnieszka Krzyzanowska, Eva Carro
BMC Neuroscience|May 17, 2011
The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epitheliumCarlos Spuch, Eva Carro
Med (New York, N.Y.)|November 15, 2025
Early screening for Alzheimer's disease: A scientific, ethical, and value-based framework for targeted screening in at-risk individualsFangya Xu, Eva Carro
Expert Review of Neurotherapeutics|April 28, 2005
Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?Eva Carro, Ignacio Torres-Aleman
European Journal of Pharmacology|April 20, 2004
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's diseaseEva Carro, Ignacio Torres-Aleman
The Keio Journal of Medicine|July 13, 2006
Serum insulin-like growth factor I in brain functionEva Carro, Ignacio Torres-Aleman
Antioxidants (Basel, Switzerland)|July 27, 2022
Oxidative Stress in Tauopathies: From Cause to TherapyFernando Bartolome, Eva Carro, Carolina Alquezar
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Expert Opinion on Therapeutic Targets|May 4, 2010
Gelsolin as therapeutic target in Alzheimer's diseaseEva Carro
Neural Regeneration Research|July 14, 2023
Implication of salivary lactoferrin and periodontal-mediated infections in Alzheimer's diseaseCristina Municio, Eva Carro
Neural Regeneration Research|December 26, 2022
Aquaporin 5 in Alzheimer's disease: a link between oral and brain pathology?Cristina Municio, Eva Carro
Frontiers in Pharmacology|May 8, 2012
Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approachesAgnieszka Krzyzanowska, Eva Carro
BMC Neuroscience|May 17, 2011
The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epitheliumCarlos Spuch, Eva Carro
Med (New York, N.Y.)|November 15, 2025
Early screening for Alzheimer's disease: A scientific, ethical, and value-based framework for targeted screening in at-risk individualsFangya Xu, Eva Carro
Expert Review of Neurotherapeutics|April 28, 2005
Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?Eva Carro, Ignacio Torres-Aleman
European Journal of Pharmacology|April 20, 2004
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's diseaseEva Carro, Ignacio Torres-Aleman
The Keio Journal of Medicine|July 13, 2006
Serum insulin-like growth factor I in brain functionEva Carro, Ignacio Torres-Aleman
Antioxidants (Basel, Switzerland)|July 27, 2022
Oxidative Stress in Tauopathies: From Cause to TherapyFernando Bartolome, Eva Carro, Carolina Alquezar
Pageof 12